Reno-30

   
Google
 
Web NewDrugInformation.com

Reno-30


Drug - Reno-30
The trade name of the product as shown on the labeling.

Dosage - SOLUTION; URETERAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Diatrizoate Meglumine
Multiple ingredients are in alphabetical order.

Strength - 30%
The potency of the active ingredient(s), Diatrizoate Meglumine. May repeat for multiple part products.

Applicant - BRACCO
The firm name holding legal responsibility for Reno-30. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 010040
The FDA assigned number to Reno-30. Format is nnnnnn.

Product Number - 021
The FDA assigned number to identify Reno-30. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Reno-30 was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Reno-30. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Reno-30 is in. Format is RX, OTC, DISCN.

Applicant Full Name - Bracco Diagnostics Inc
The full name of the firm holding legal responsibility for the new application of Reno-30.

Reno-30